AccessibilityHelpAbout Us
Oxford Nanopore Technologies Plc logo

Oxford Nanopore Technologies Plc(OTC) ONTTF

Market Cap$2.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-72%
5 YearN/A
1 Year+7%
1 Month+33%
$2.10
-12.50%
-0.30Today
Oxford Nanopore Technologies Plc last closing stock price
MetricPriceDate
Last closeUSD 2.402026-09-18
Oxford Nanopore Technologies Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+17.07%USD 2.052026-09-10
1 month+33.33%USD 1.802026-08-19
3 month+52.28%USD 1.582026-06-18
Year to date+39.53%USD 1.722025-12-31
1 year+6.67%USD 2.252025-09-18
3 year-9.09%USD 2.642023-09-19
Since inception-71.99%USD 8.572021-10-15

Oxford Nanopore Technologies Plc Financials at a Glance

Market Cap

$2.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£438.83M

Net Income (TTM)

-£264.37M

EPS (TTM)

-$0.17

P/E Ratio

-14.24

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.10

Volume

6,072

Open

$2.32

Previous Close

$2.10

Daily Range

$2.10 - $2.32

52-Week Range

$1.27 - $2.59

Estimated Earnings Date

Mar 9, 2027

ONTTF News

Medical-gloved hand holding human DNA in front of sequence imaging.jpg

4 Best Genetic Sequencing Stocks for 2026 and How to Invest

Keith SpeightsSep 13, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc is a pioneering biotechnology company focused on developing and commercializing innovative nanopore-based sensing technology. This technology enables the analysis of various types of molecules, including DNA and RNA, through a range of advanced sequencing devices.

Products and Services
  • MinION: A portable device for DNA and RNA sequencing
  • GridION: A benchtop instrument for multi-sample analysis
  • EPI2ME: A cloud-based platform for real-time data analysis
Growth Outlook
  • Revenue of £115.86 million reported in Q2 2026, showing strong demand
  • Gross profit margin improved to 62.2% in Q2 2026
  • Continued investment in R&D, with £36.63 million spent in Q2 2026
Financial Highlights
  • Net income of -£47.65 million in Q2 2026, reflecting ongoing investment
  • Cash and cash equivalents of £141.67 million as of June 2026
  • Current ratio of 3.52, indicating strong liquidity position
Oxford Nanopore Technologies plc stands out in the biotechnology sector with its unique approach to molecular analysis. The company's product offerings cater to a wide range of applications, from academic research to clinical diagnostics. The recent quarterly results indicate a robust revenue stream and a commitment to innovation through significant R&D expenditures. Despite reporting a net loss, the company maintains a healthy liquidity position, which is crucial for sustaining growth and development in a competitive market. The strong gross profit margin suggests effective cost management and pricing strategies, positioning the company favorably for future expansion.
AI Generated • Sep 20, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

1,403

CEO

Gordon Sanghera, PhD

Website

nanoporetech.com

Headquarters

Oxford, OXF OX4 4DQ, GB

ONTTF Financials

Key Financial Metrics (TTM)

Gross Margin

60.18%

Operating Margin

-58.06%

Net Income Margin

-54.66%

Return on Equity

-35.45%

Return on Capital

-25.42%

Return on Assets

-27.82%

Earnings Yield

-7.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

977.50M

Volume

6.07K

Avg. Volume

25.47K

Financials (TTM)

Gross Profit

£259.29M

Operating Income

-£280.92M

EBITDA

-£187.44M

Operating Cash Flow

-£156.03M

Capital Expenditure

-£34.10M

Free Cash Flow

-£195.19M

Cash & ST Invst.

£183.47M

Total Debt

£41.50M

Oxford Nanopore Technologies Plc Performance Analysis

Oxford Nanopore Technologies Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 244,635,23933.1%
20232023-12-31GBP 210,906,120-13.8%
20242024-12-31GBP 234,083,71511.0%
20252025-12-31GBP 295,075,62926.1%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3117.9%
Q22025-06-306.5%
Q42025-12-3112.0%
Q22026-06-30-2.0%
Oxford Nanopore Technologies Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.14-51.5%
20232023-12-31GBP -0.2369.2%
20242024-12-31GBP -0.21-9.6%
20252025-12-31GBP -0.20-4.3%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3111.5%
Q22025-06-302.2%
Q42025-12-31-0.3%
Q22026-06-3034.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£115.86M

+37.8%

Gross Profit

£72.08M

+45.7%

Gross Margin

62.21%

N/A

Market Cap

$2.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.67M

N/A

Employees

1,403

N/A

Net Income

-£47.65M

+36.2%

EBITDA

-£21.84M

+65.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£183.47M

-29.1%

Total Debt

£41.50M

-11.1%

Accounts Receivable

£91.93M

+50.6%

Inventory

£79.82M

-26.1%

Long Term Debt

£35.84M

-13.8%

Short Term Debt

£5.66M

+10.4%

Return on Assets

-27.82%

N/A

Return on Invested Capital

-36.03%

N/A

Free Cash Flow

-£41.20M

+45.1%

Operating Cash Flow

-£39.12M

+34.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MEOBFMesoblast Limited
$1.90+0.00%
GENSFGenus plc
$28.50-8.26%
PHMMFPharma Mar, S.A.
$94.60+0.00%
BRCTFBioArctic AB (publ)
$36.92+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
WBDWarner Bros. Discovery
$30.80+10.79%
GRMLGreenland Mines
$9.42+230.53%
INTCIntel
$121.78+12.14%
NVDANvidia
$227.38+2.30%

Questions About ONTTF

What is the current price of Oxford Nanopore Technologies Plc?

Oxford Nanopore Technologies Plc is trading at $2.10 per share.

What is the 52-week range for Oxford Nanopore Technologies Plc?

Over the past 52 weeks, Oxford Nanopore Technologies Plc has traded between $1.27 and $2.59.

How much debt does Oxford Nanopore Technologies Plc have?

As of the most recent reporting period, Oxford Nanopore Technologies Plc reported total debt of £55.82M.

How much cash does Oxford Nanopore Technologies Plc have on hand?

Oxford Nanopore Technologies Plc reported £243.59M in cash and cash equivalents in its most recent financial results.

What is Oxford Nanopore Technologies Plc’s dividend yield?

Oxford Nanopore Technologies Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services